全文获取类型
收费全文 | 2082篇 |
免费 | 278篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 95篇 |
妇产科学 | 45篇 |
基础医学 | 236篇 |
口腔科学 | 30篇 |
临床医学 | 218篇 |
内科学 | 466篇 |
皮肤病学 | 40篇 |
神经病学 | 133篇 |
特种医学 | 287篇 |
外科学 | 169篇 |
综合类 | 97篇 |
一般理论 | 3篇 |
预防医学 | 299篇 |
眼科学 | 22篇 |
药学 | 192篇 |
肿瘤学 | 83篇 |
出版年
2021年 | 33篇 |
2020年 | 13篇 |
2019年 | 13篇 |
2018年 | 26篇 |
2017年 | 25篇 |
2016年 | 26篇 |
2015年 | 30篇 |
2014年 | 38篇 |
2013年 | 56篇 |
2012年 | 54篇 |
2011年 | 64篇 |
2010年 | 57篇 |
2009年 | 59篇 |
2008年 | 91篇 |
2007年 | 113篇 |
2006年 | 87篇 |
2005年 | 106篇 |
2004年 | 84篇 |
2003年 | 53篇 |
2002年 | 93篇 |
2001年 | 81篇 |
2000年 | 57篇 |
1999年 | 63篇 |
1998年 | 71篇 |
1997年 | 68篇 |
1996年 | 70篇 |
1995年 | 71篇 |
1994年 | 48篇 |
1993年 | 62篇 |
1992年 | 48篇 |
1991年 | 45篇 |
1990年 | 51篇 |
1989年 | 81篇 |
1988年 | 62篇 |
1987年 | 53篇 |
1986年 | 34篇 |
1985年 | 41篇 |
1984年 | 29篇 |
1983年 | 22篇 |
1982年 | 22篇 |
1981年 | 27篇 |
1980年 | 29篇 |
1979年 | 28篇 |
1978年 | 12篇 |
1977年 | 18篇 |
1976年 | 21篇 |
1975年 | 13篇 |
1971年 | 8篇 |
1970年 | 13篇 |
1968年 | 13篇 |
排序方式: 共有2425条查询结果,搜索用时 15 毫秒
61.
62.
63.
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort 总被引:2,自引:0,他引:2
Urowitz MB Gladman D Ibañez D Fortin P Sanchez-Guerrero J Bae S Clarke A Bernatsky S Gordon C Hanly J Wallace D Isenberg D Ginzler E Merrill J Alarcón GS Steinsson K Petri M Dooley MA Bruce I Manzi S Khamashta M Ramsey-Goldman R Zoma A Sturfelt G Nived O Maddison P Font J van Vollenhoven R Aranow C Kalunian K Stoll T;Systemic Lupus International Collaborating Clinics 《Arthritis and rheumatism》2008,59(2):176-180
OBJECTIVE: To examine the accumulation of risk factors over 3 years in a multicenter, international inception cohort of patients with systemic lupus erythematosus (SLE). METHODS: The Systemic Lupus International Collaborating Clinics registry for atherosclerosis comprises 27 centers from 11 countries. An inception cohort of 935 patients with SLE was assembled, according to a standardized protocol, from 2000 to 2006 to study risk factors for atherosclerosis. Both classic and other coronary artery disease (CAD) risk factors were collected at entry and through 3 years of followup. Therapy was documented over the 3 years. The Framingham 10-year risk factor profile was calculated for each patient at year 1 and year 3. RESULTS: A total of 278 patients from the inception cohort were followed for 3 years and constituted the population for this study. At enrollment a substantial number of patients already demonstrated several risk factors for CAD, both classic and other. All risk factors increased from enrollment over the 3 years of followup. Treatment of hypertension and hypercholesterolemia also increased over 3 years, but less so for hypercholesterolemia. The Framingham 10-year CAD risk profile was higher in men than in women both at entry and at 3 years, and remained unchanged over the 3 years. Corticosteroid use increased only slightly over 3 years, but use of antimalarials and immunosuppressive agents increased to a greater extent. CONCLUSION: Patients with SLE should be monitored for CAD risk factors from the time of diagnosis and appropriate treatment should be instituted early. 相似文献
64.
The epidemiology of hyperuricaemia and gout in Taiwan aborigines 总被引:4,自引:1,他引:4
To determine the prevalence of hyperuricaemia, gout and gout-related
factors in Central Taiwan Atayal aborigines, 342 subjects over 18 yr old
were interviewed and examined. A questionnaire was designed to screen for
signs and symptoms of gout and gout-related risk factors. Serum uric acid,
triglyceride and creatinine were measured in all subjects. The prevalence
of hyperuricaemia was 41.4% and that of gout 11.7% in aborigines. The uric
acid level was 7.9+/-1.7 mg/dl in males and 5.7+/-1.5 in females, and
differed significantly under age 70 yr (P < 0.001). Significantly
increased triglyceride, creatinine and alcoholism was found in gouty
patients compared with non-gouty patients. In 40 cases with gout, 54% had
tophi and 35% of their first- degree relatives had gout. The high
prevalence of hyperuricaemia and gout in Taiwan Atayal aborigines, a
significant family predisposition, increased creatinine level and
alcoholism suggest multiple factors affecting the hyperuricaemia.
相似文献
65.
66.
Ortiz-Alvarez O; Cabral D; Prendiville JS; Stringer D; Petty RE; Malleson PN 《Rheumatology (Oxford, England)》1997,36(2):280-284
Two children are reported in whom intestinal pseudo-obstruction was the
initial manifestation of systemic sclerosis. Gastrointestinal symptoms and
skin changes resolved or improved in both children following treatment with
prednisone and penicillamine (case 1) or methotrexate (case 2), although
radiological changes of the gastrointestinal tract persisted at 3 and 2 yr
of follow-up, respectively.
相似文献
67.
Coakley G; Mok CC; Hajeer AH; Ollier WE; Turner D; Sinnott PJ; Hutchinson IV; Panayi GS; Lanchbury JS 《Rheumatology (Oxford, England)》1998,37(9):988-991
OBJECTIVE: To examine whether promoter polymorphisms associated with
variation in interleukin-10 (IL-10) production are relevant to the
development of rheumatoid arthritis (RA) or Felty's syndrome (FS). METHODS:
DNA was obtained from 44 FS patients, 117 RA patients and 295 controls. The
promoter region between -533 and - 1120 was amplified by polymerase chain
reaction, and polymorphisms detected by restriction enzyme digest or
sequence-specific oligonucleotide probing. RESULTS: We found no significant
difference in allele or haplotype frequencies between the groups.
CONCLUSION: There is no association between FS or RA and these recently
identified IL-10 promoter polymorphisms. Other genetic or environmental
factors could explain the alterations in IL-10 levels seen in these
conditions.
相似文献
68.
69.
J. S. Dooley A. Gooding J. M. T. Hamilton-Miller W. Brumfitt S. Sherlock 《Liver international》1983,3(4):201-206
ABSTRACT— The biliary excretion and pharmacokinetics of mezlocillin have been studied in jaundiced patients with total external bile drainage through a percutaneous transhepatic catheter. In 10 of 11 studies, 2 g mezlocillin intravenously resulted in biliary concentrations sufficient to exceed the minimum inhibitory concentrations of most common biliary pathogenic organisms. In 6 h, 0.2–6.2% of the dose given was recovered in bile. The biliary clearance was 0.21–7.82 ml/min and increased with the duration of biliary decompression. The serum half-life of mezlocillin was prolonged (1.81 ± 0.23 h, mean ± SD), and was due to reduced biliary and renal clearance. 相似文献
70.
Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. 总被引:4,自引:0,他引:4
Hong-Lei Weng Bao-En Wang Ji-Dong Jia Wan-Fen Wu Jian-Zhong Xian Peter R Mertens Wei-Min Cai Steven Dooley 《Clinical gastroenterology and hepatology》2005,3(8):819-828
BACKGROUND & AIMS: Hepatic fibrosis due to chronic HBV infection has enormous socioeconomic impact. Besides strategies targeting virus elimination, prevention or reversal of liver fibrosis is amenable. Given the antifibrotic activity of interferon-gamma (IFN-gamma), a randomized open-labeled multicenter trial was initiated to test IFN-gamma in HBV infection. METHODS: HBsAg-positive patients with biopsy proven hepatic fibrosis (n = 99, stages 2-4, Scheuer criterion) were treated with diammone-glycyrrhizinate and potassium-magnesium aspartate. Sixty-six randomly assigned patients were treated with 50 mug IFN-gamma intramuscularly on a daily basis for 3 months and on alternate days the subsequent 6 months. Efficacy was evaluated by liver biopsy and serologic markers. RESULTS: Fifty-four patients in the IFN-gamma group and 29 patients in the control group completed the study. The hepatic fibrosis score was significantly reduced in 63% of IFN-gamma treated patients compared with 24.1% in the control group by using a semiquantitative scoring system evaluating both liver architecture and fibrotic deposits. Mean values for the total fibrosis score decreased from 13.8 +/- 5.8 to 10.1 +/- 5.1 in the IFN-gamma group (P = .0001), whereas they were unchanged in control subjects (13.2 +/- 6.8 vs 12.6 +/- 4.8, P = .937). The Scheuer system showed 12 out of 54 patients improved >or=1 stage(s) in the IFN-gamma group compared with 1 of 29 in the control group. Antifibrotic activity might be attributed to decreased transforming growth factor-beta signaling via phosphorylated Smad2 and reduced number of activated, alpha-smooth muscle actin positive hepatic stellate cells. CONCLUSIONS: IFN-gamma treatment for 9 months improves fibrosis scores in patients with chronic HBV infection most likely by antagonizing profibrogenic transforming growth factor-beta effects. 相似文献